Home » Topics » Conferences

Conferences
RSS

CGP-25454 tested in healthy volunteers

Aug. 30, 1996

Correlation established between serum PLA2 activity and schizophrenia symptoms

Aug. 30, 1996

Potential antipsychotic described by Parke-Davis

Aug. 30, 1996

Famotidine tested in schizophrenic patients

Aug. 30, 1996

DuPont Merck reports on CRH antagonists for anxiety, depression

Aug. 30, 1996

Russian investigators describe new tranquilizer

Aug. 30, 1996

Flunitrazepam may alter circadian sleep-wake rhythms

Aug. 30, 1996

SDZ-266806: A novel squalene synthase inhibitor

Aug. 30, 1996

New agents for use in transplantation

Aug. 30, 1996

FR-173657: Fujisawa's bradykinin B2 antagonist

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...